In a study, published in Nature Communications, researchers demonstrated that simultaneous treatment of TB and HIV effectively suppresses TB reactivation during co-infection but fails to mitigate the chronic immune activation. This new evidence sheds light on the intricate immunological interplay between these two pathogens and challenges existing therapeutic paradigms.
Read the full news story here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #38, 12 December 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Source : Bioengineer.org
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.